We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Arianna Kim

Arianna Kim PhD

Department of Dermatology, Columbia University Irving Medical Center, New York, New York

Dr. Kim’s research focuses on identifying the molecular and cellular components that influence cancer cell survival and elucidating how these factors contribute to the pathogenesis of nonmelanoma skin cancers (NMSC). Dr. Kim’s current research topics include 1) identification of additional genetic and epigenetic targets driving NMSCs, 2) mechanisms by which the bromodomain (BRD)-containing protein 7 (BRD7) and BRD9 of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complexes influence BCC growth, and 3) development of mechanism-driven combinatorial treatment strategies for the prevention and treatment of NMSCs.

Disclosures

Dr. Kim has no relevant disclosures.